日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Integration of drug safety monitoring in tuberculosis treatment programmes: country experiences

将药物安全监测纳入结核病治疗方案:各国经验

Tiemersma, Edine; van den Hof, Susan; Dravniece, Gunta; Wares, Fraser; Molla, Yohannes; Permata, Yusie; Lukitosari, Endang; Quelapio, Mamel; Aung, Si Thu; Aung, Khay Mar; Thuy, Hoang Thanh; Hoa, Vu Dinh; Sulaimanova, Merkinai; Sagyndikova, Saadat; Makhmudova, Mavluda; Soliev, Alijon; Kimerling, Michael

Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project.

结核分枝杆菌分离株对吡嗪酰胺和氟喹诺酮类药物的群体耐药性:一项多国监测项目的结果

Zignol Matteo, Dean Anna S, Alikhanova Natavan, Andres Sönke, Cabibbe Andrea Maurizio, Cirillo Daniela Maria, Dadu Andrei, Dreyer Andries, Driesen Michèle, Gilpin Christopher, Hasan Rumina, Hasan Zahra, Hoffner Sven, Husain Ashaque, Hussain Alamdar, Ismail Nazir, Kamal Mostofa, Mansjö Mikael, Mvusi Lindiwe, Niemann Stefan, Omar Shaheed V, Qadeer Ejaz, Rigouts Leen, Ruesch-Gerdes Sabine, Schito Marco, Seyfaddinova Mehriban, Skrahina Alena, Tahseen Sabira, Wells William A, Mukadi Ya Diul, Kimerling Michael, Floyd Katherine, Weyer Karin, Raviglione Mario C

Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models

中国、印度和南非积极防治结核病的成本效益和资源影响:九个模型的综合分析

Menzies, Nicolas A; Gomez, Gabriela B; Bozzani, Fiammetta; Chatterjee, Susmita; Foster, Nicola; Baena, Ines Garcia; Laurence, Yoko V; Qiang, Sun; Siroka, Andrew; Sweeney, Sedona; Verguet, Stéphane; Arinaminpathy, Nimalan; Azman, Andrew S; Bendavid, Eran; Chang, Stewart T; Cohen, Ted; Denholm, Justin T; Dowdy, David W; Eckhoff, Philip A; Goldhaber-Fiebert, Jeremy D; Handel, Andreas; Huynh, Grace H; Lalli, Marek; Lin, Hsien-Ho; Mandal, Sandip; McBryde, Emma S; Pandey, Surabhi; Salomon, Joshua A; Suen, Sze-Chuan; Sumner, Tom; Trauer, James M; Wagner, Bradley G; Whalen, Christopher C; Wu, Chieh-Yin; Boccia, Delia; Chadha, Vineet K; Charalambous, Salome; Chin, Daniel P; Churchyard, Gavin; Daniels, Colleen; Dewan, Puneet; Ditiu, Lucica; Eaton, Jeffrey W; Grant, Alison D; Hippner, Piotr; Hosseini, Mehran; Mametja, David; Pretorius, Carel; Pillay, Yogan; Rade, Kiran; Sahu, Suvanand; Wang, Lixia; Houben, Rein M G J; Kimerling, Michael E; White, Richard G; Vassall, Anna

Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models

南非、中国和印度实现世卫组织2025年全球结核病防治目标的可行性:11个数学模型的综合分析

Houben, Rein M G J; Menzies, Nicolas A; Sumner, Tom; Huynh, Grace H; Arinaminpathy, Nimalan; Goldhaber-Fiebert, Jeremy D; Lin, Hsien-Ho; Wu, Chieh-Yin; Mandal, Sandip; Pandey, Surabhi; Suen, Sze-Chuan; Bendavid, Eran; Azman, Andrew S; Dowdy, David W; Bacaër, Nicolas; Rhines, Allison S; Feldman, Marcus W; Handel, Andreas; Whalen, Christopher C; Chang, Stewart T; Wagner, Bradley G; Eckhoff, Philip A; Trauer, James M; Denholm, Justin T; McBryde, Emma S; Cohen, Ted; Salomon, Joshua A; Pretorius, Carel; Lalli, Marek; Eaton, Jeffrey W; Boccia, Delia; Hosseini, Mehran; Gomez, Gabriela B; Sahu, Suvanand; Daniels, Colleen; Ditiu, Lucica; Chin, Daniel P; Wang, Lixia; Chadha, Vineet K; Rade, Kiran; Dewan, Puneet; Hippner, Piotr; Charalambous, Salome; Grant, Alison D; Churchyard, Gavin; Pillay, Yogan; Mametja, L David; Kimerling, Michael E; Vassall, Anna; White, Richard G

Defining the needs for next generation assays for tuberculosis

明确下一代结核病检测方法的需求

Denkinger, Claudia M; Kik, Sandra V; Cirillo, Daniela Maria; Casenghi, Martina; Shinnick, Thomas; Weyer, Karin; Gilpin, Chris; Boehme, Catharina C; Schito, Marco; Kimerling, Michael; Pai, Madhukar

Alignment of new tuberculosis drug regimens and drug susceptibility testing: a framework for action

结核病新药方案与药物敏感性检测的协调一致:行动框架

Wells, William A; Boehme, Catharina C; Cobelens, Frank G J; Daniels, Colleen; Dowdy, David; Gardiner, Elizabeth; Gheuens, Jan; Kim, Peter; Kimerling, Michael E; Kreiswirth, Barry; Lienhardt, Christian; Mdluli, Khisi; Pai, Madhukar; Perkins, Mark D; Peter, Trevor; Zignol, Matteo; Zumla, Alimuddin; Schito, Marco

Clinical research and development of tuberculosis diagnostics: moving from silos to synergy

结核病诊断的临床研究与开发:从各自为政走向协同合作

Nahid, Payam; Kim, Peter S; Evans, Carlton A; Alland, David; Barer, Michael; Diefenbach, Jane; Ellner, Jerrold; Hafner, Richard; Hamilton, Carol Dukes; Iademarco, Michael F; Ireton, Gregory; Kimerling, Michael E; Lienhardt, Christian; MacKenzie, William R; Murray, Megan; Perkins, Mark D; Posey, Jamie E; Roberts, Teri; Sizemore, Christine; Stevens, Wendy S; Via, Laura; Williams, Sharon D; Yew, Wing W; Swindells, Susan

Use of anti-retroviral therapy in tuberculosis patients on second-line anti-TB regimens: a systematic review

在接受二线抗结核治疗方案的结核病患者中使用抗逆转录病毒疗法:系统评价

Arentz, Matthew; Pavlinac, Patricia; Kimerling, Michael E; Horne, David J; Falzon, Dennis; Schünemann, Holger J; Royce, Sarah; Dheda, Keertan; Walson, Judd L

Size and usage patterns of private TB drug markets in the high burden countries

高负担国家私人结核病药物市场的规模和使用模式

Wells, William A; Ge, Colin Fan; Patel, Nitin; Oh, Teresa; Gardiner, Elizabeth; Kimerling, Michael E

Bloodstream infections among HIV-infected outpatients, Southeast Asia

东南亚艾滋病毒感染门诊患者的血液感染情况

Varma, Jay K; McCarthy, Kimberly D; Tasaneeyapan, Theerawit; Monkongdee, Patama; Kimerling, Michael E; Buntheoun, Eng; Sculier, Delphine; Keo, Chantary; Phanuphak, Praphan; Teeratakulpisarn, Nipat; Udomsantisuk, Nibondh; Dung, Nguyen H; Lan, Nguyen T N; Yen, Nguyen T B; Cain, Kevin P